2840 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Dahi
    Dahi
  4. Ponce
    Ponce
  5. Shah
    Shah
  6. Sauter
    Sauter
  7. Scordo
    Scordo
  8. Jakubowski
    Jakubowski
  9. Papadopoulos
    Papadopoulos
  10. Devlin
    Devlin

Groups

  1. MSK Grad Students (2840)
  2. GSK Faculty (1991)
  3. Department of Medicine (1592)
  4. Sloan Kettering Institute Postdocs (1579)
  5. Sloan Kettering Institute Faculty (1299)
  6. Center for Hematologic Malignancies (1109)
  7. Hematologic Malignancies, Division of (993)
  8. CTCR Scholars (988)
  9. Master of Science in Clinical and Translational Cancer Research (955)
  10. Epidemiology and Biostatistics (734)
  1. "MSK Grad Students"
Formats
  1. Journal Article (1632)
  2. Meeting Abstract (965)
  3. Review (105)
  4. Editorial (42)
  5. Research Letter (35)
  6. Miscellaneous (19)
  7. Correspondence (15)
  8. Conference Paper (12)
  9. Book Section (9)
  10. Guidelines (6)
Groups
  1. MSK Grad Students (2840)
  2. GSK Faculty (1991)
  3. Department of Medicine (1592)
  4. Sloan Kettering Institute Postdocs (1579)
  5. Sloan Kettering Institute Faculty (1299)
  6. Center for Hematologic Malignancies (1109)

More Groups

People
  1. Sergio Giralt (392)
  2. Miguel-Angel Perales (376)
  3. Parastoo Dahi (294)
  4. Sean Devlin (277)
  5. Doris Ponce (254)
  6. Roni Tamari (208)

More People

Years
  1. 2025 (94)
  2. 2024 (256)
  3. 2023 (312)
  4. 2022 (334)
  5. 2021 (289)
  6. 2020 (378)

More Years

Publications
  1. Blood (294)
  2. Biology of Blood and Marrow Transplantation (165)
  3. Cancer Research (132)
  4. Journal of Clinical Oncology (127)
  5. Nature Communications (96)
  6. Nature (85)

More Publications

Publishers
  1. Nature Publishing Group (435)
  2. American Society of Hematology (331)
  3. Elsevier Inc. (298)
  4. Cell Press (272)
  5. American Association for Cancer Research (265)
  6. American Society of Clinical Oncology (143)

More Publishers

Results (2840)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation
    Meeting Abstract

    Tejura, B.; Kosuri, S.; Khera, N.; DeFilipp, M. Z.; Lombardo, M. J.; Ford, C.; Peled, J. U.; van den Brink, M. R. M.; von Moltke, L.; Ponce, D. M.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Geriatric assessment and outcomes of allogeneic hematopoietic cell transplantation in older patients
    Meeting Abstract

    Dahi, P. B.; Shahrokni, A.; Flynn, J.; Devlin, S. M.; Chinapen, S. A.; Ayala, J.; Brown, S.; Bugen, S.; Cho, C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A prospective study of allogeneic stem cell transplantation of A/B T-lymphocyte depleted graft conditioned with a reduced intensity regimen in patients with hematologic malignancies
    Meeting Abstract

    Tamari, R.; Flynn, J.; Shaffer, B.; Jakubowski, A.; Papadopoulos, E.; Devlin, S.; Lin, R.; Giralt, S.; Perales, M. A.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Sean, M. D.; Parastoo, D.; Heather, J. L.; Oscar, B. L.; Michael, S.; Gunjan, L. S.; David, J. C.; Hani, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Aspire to ASCENT: Real-world outcomes from patients with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (Saci) in a single academic institution
    Meeting Abstract

    Walsh, E. M.; Klar, M.; Abuhadra, N.; Robson, M.; Drago, J.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • An impaired ubiquitin-proteasome system increases APOBEC3A abundance
    Journal Article

    Coxon, M.; Dennis, M. A.; Dananberg, A.; Collins, C. D.; Wilson, H. E.; Meekma, J.; Savenkova, M.; Ng, D.; Osbron, C. A.; Mertz, T. M.; more...
    Nar Cancer (2023)

    Fulltext@MSK | Save
  • Host interactions with engineered T-cell micropharmacies
    Journal Article

    Bourne, C. M.; Wallisch, P.; Dacek, M. M.; Gardner, T. J.; Pierre, S.; Vogt, K.; Corless, B. C.; Bah, M. A.; Romero-Pichardo, J. E.; Charles, A.; more...
    Cancer Immunology Research (2023)

    Fulltext@MSK | Save
  • Nanosensor-based monitoring of autophagy-associated lysosomal acidification in vivo
    Journal Article

    Kim, M.; Chen, C.; Yaari, Z.; Frederiksen, R.; Randall, E.; Wollowitz, J.; Cupo, C.; Wu, X.; Shah, J.; Worroll, D.; more...
    Nature Chemical Biology (2023)

    Fulltext@MSK | Save
  • Challenges and solutions for therapeutic TCR-based agents
    Review

    Malviya, M.; Aretz, Z. E. H.; Molvi, Z.; Lee, J.; Pierre, S.; Wallisch, P.; Dao, T.; Scheinberg, D. A.
    Immunological Reviews (2023)

    Fulltext@MSK | Save